306
Participants
Start Date
December 31, 2011
Primary Completion Date
November 30, 2013
Study Completion Date
December 31, 2013
pregabalin
150 - 300 mg/day in divided dose (3 time a day) for 6 weeks
placebo
matching placebo 3 time a day
The Medical Research Network, LLC, New York
Blair Orthopedic Associates, Inc., Altoona
Altoona Center for Clinical Research, Duncansville
Davidson Medical Ministries, Lexington
Neurology and Pain Clinic, LLC, Orangeburg
Columbus Research Foundation, Columbus
MD Clinical, Hallandale
AGA Clinical Trials, Hialeah
Palm Beach Neurological Center,, Palm Beach Gardens
Meridien Research, Tampa
Meridien Research, St. Petersburg
Clinical Research of Central Florida, Winter Haven
Gulfcoast Clinical Research Center, Fort Myers
Meridien Research, Bradenton
Meridien Research, Brooksville
New Phase Research and Development, Knoxville
UNARS, s.r.o., Pelhřimov
Central Kentucky Research Associates, Inc., Lexington
Radiant Research, Columbus
Radiant Research (admin office), Cincinnati
Borgess Diabetes Center, Kalamazoo
Borgess Research Institute, Kalamazoo
Suburban Clinical Research, Naperville
Suburban Clinical Research, Chicago
Mercy Health Research, St Louis
Quality Clinical Research, Inc., Omaha
Arthritis and Diabetes Clinic, Inc., Monroe
Sooner Clinical Research, Oklahoma City
The Office of Veronique Sebastian, MD, Oklahoma City
University of Texas Southwestern Medical Center at Dallas, Dallas
Houston Neurocare, Houston
Centex Research, Inc., Houston
Clinical Research Consortium, Phoenix
Arizona Research Center, Phoenix
Advanced Podiatry, Phoenix
Precision Trials, Phoenix
The Office of Joshua D. Holland, M.D., Phoenix
Dedicated Clinical Research, Goodyear
Genova Clinical Research, Tucson
Clinical Research Consortium, Las Vegas
Mirkil Medical Group, Las Vegas
V.Jerome Mirkil, MD, Las Vegas
HealthCare Partners Medical Group, Los Angeles
IDS Pharmacy, Los Angeles
University of Southern California, Los Angeles
National Research Institute, Los Angeles
Center for United Research, Inc., Lakewood
Neuro-Pain Medical Center, Fresno
Diablo Clinical Research, Inc., Walnut Creek
Sunstone Medical Research, LLC, Medford
Coastal Connecticut Research, LLC, New London
Neurological Group, PC, New London
Chase Medical Research, LLC, Waterbury
Beacon Clinical Research, LLC, Brockton
Miray Medical Center, Brockton
Genesis Clinical Research, LLC, Fall River
Clintrial, s.r.o., Prague
Fakultni nemocnice v Motole, Prague
Fondazione PTV Policlinico Tor Vergata di Roma, Roma
Center for Lakemedelsstudier, Malmo
Citydiabetes, Stockholm
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY